Global Pertussis Vaccine Market Size By Type of Vaccine, By Age Group, By Distribution Channel, By Geographic Scope And Forecast

Pertussis Vaccine Market Size And Forecast

Pertussis Vaccine Market size was valued at USD 8612.77 Million in 2023 and is projected to reach USD 15429.81 Million by 2032, growing at a CAGR of 8.34% during the forecast period 2026-2032.

Global Pertussis Vaccine Market Drivers

The market drivers for the Pertussis Vaccine Market can be influenced by various factors. These may include:

Growing Incidence of Pertussis: The market is significantly influenced by the growing prevalence of pertussis, also known as whooping cough. The necessity for immunisation to stop the disease's spread is growing as it continues to harm people all over the world.

Government Initiatives and Immunisation Programmes: As part of regular vaccination schedules, a number of governments and healthcare organisations are actively promoting immunisation against pertussis. Programmes aimed for babies, kids, teens, and adults are included in this, which helps the industry expand.

Technological Developments in Vaccines: Newer and safer pertussis vaccinations have been made possible by technological advancements in vaccine research. Growth in the market is fueled by these developments, which draw funding for R&D.

Education and Public Awareness Campaigns: Raising public awareness of the value of the pertussis vaccination through educational programmes and campaigns is essential to increasing demand. Vaccine uptake is boosted by greater awareness among the general public and healthcare professionals.

Increase in Healthcare Spending: The market for pertussis vaccine is growing as a result of the general increase in healthcare spending, especially in preventative healthcare measures. This covers funding for immunisation campaigns and the infrastructure needed to distribute vaccines.

Growing Interest in Paediatric Vaccination: There will likely be a continued high demand for pertussis vaccines due to the increased attention being paid to paediatric healthcare and the health of newborns and children. Pertussis vaccine is frequently included in paediatric vaccination schedules, which is fueling market expansion.

Globalisation and Travel: The ease with which people can travel the world has raised the possibility of spreading diseases, such as pertussis. Traveller vaccination laws, particularly in areas where pertussis is more common, aid in the growth of the industry.

Partnerships and Collaborations: These partnerships and collaborations assist market growth by facilitating vaccine access, distribution, and affordability between healthcare providers, government agencies, non-profit organisations, and vaccine makers.

Global Pertussis Vaccine Market Restraints

Several factors can act as restraints or challenges for the Pertussis Vaccine Market. These may include:

Limited Knowledge and Access: There may be limited knowledge about the pertussis vaccination in some areas, particularly in low-income or isolated communities, or there may be limited access to medical facilities that provide vaccination services. This may impede market expansion by limiting the reach of immunisation initiatives.

Vaccination expense: The expense of the pertussis vaccination can be a major obstacle, especially for people without insurance or in private healthcare settings. Affordability concerns could prevent some demographic segments from receiving vaccinations, which would hinder market expansion.

Difficulties with Vaccine Distribution and Storage: Pertussis vaccinations frequently need particular storage environments, such refrigeration, which can be logistically difficult, particularly in rural or underdeveloped locations. Keeping the cold chain intact increases the process's complexity and expense.

Vaccine Hesitancy and Safety worries: Similar to any medical procedure, vaccinations may cause certain people or groups to have safety worries. Inaccurate information or a lack of faith in medical institutions can cause vaccine hesitation, which can impede market growth and reduce immunisation rates.

Regulatory Obstacles: varied nations and areas have varied regulatory regulations for the distribution and licencing of vaccines. For vaccine producers, adhering to strict regulations on clinical studies and manufacturing procedures can be difficult, which might hinder their ability to enter and grow new markets.

Competitive Environment: There may be pressure on prices and lower profit margins due to the existence of several vaccine makers and competition in the Pertussis Vaccine Market. Businesses may encounter difficulties efficiently differentiating their products and gaining market share.

Public Health Policies and financing: The demand for pertussis vaccinations may be impacted by modifications to public health policies, changes in government financing for immunisation programmes, and variations in healthcare budgets. Market volatility may result from unclear long-term funding or policy changes.

Global Pertussis Vaccine Market Segmentation Analysis

The Global Pertussis Vaccine Market is Segmented on the basis of Type of Vaccine, Age Group, Distribution Channel, and Geography.

Pertussis Vaccine Market, By Type of Vaccine

• Whole-cell Pertussis Vaccines: These vaccines contain whole, killed Bordetella pertussis bacteria. They were the first type of pertussis vaccines developed and used widely in the past. However, they are associated with more side effects compared to acellular vaccines.
• Acellular Pertussis Vaccines: These vaccines contain purified components of the Bordetella pertussis bacteria, such as pertussis toxin, filamentous hemagglutinin, pertactin, and fimbriae. They are newer and generally have fewer side effects, making them preferred for routine immunization.

Pertussis Vaccine Market, By Age Group

• Infants: Pertussis vaccination in infants is crucial as they are more susceptible to severe complications of pertussis, such as pneumonia and seizures.
• Children: Continued vaccination during childhood ensures sustained protection against pertussis.
• Adults: Vaccination in adults, especially pregnant women and healthcare workers, helps prevent the transmission of pertussis to vulnerable populations.

Pertussis Vaccine Market, By Distribution Channel

• Hospitals and Clinics: These are primary channels for vaccination, especially for infants and children during routine healthcare visits.
• Retail Pharmacies: Increasingly important for adult vaccinations and convenience for individuals seeking booster doses.
• Online Pharmacies: Emerging as a convenient option for vaccine distribution, especially during the COVID-19 pandemic when remote access to healthcare services has become more prevalent.

Pertussis Vaccine Market, By Geography

• North America: Market conditions and demand in the United States, Canada, and Mexico.
• Europe: Analysis of the Pertussis Vaccine Market in European countries.
• Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa: Examining market dynamics in the Middle East and African regions.
• Latin America: Covering market trends and developments in countries across Latin America.

Key Players

• The major players in the Pertussis Vaccine Market are:
• Kubota
• Deluxe Agro Industries
• AGCO
• Bharat Industries
• Iseki & Co
• ALMACO
• Alvan Blanch
• Wuhan Acme Agro Tech.
• GlaxoSmithKline
• Sanofi Pasteur
• Pfizer Inc.
• Serum Institute of India Pvt Ltd